Rob Stein
AACR-June L. Biedler Prize for Cancer Journalism - Radio Category

Rob Stein

National Public Radio

Rob Stein, “Scientists Race to Improve Living Drugs for Cancer

In this piece, Stein educates his audience about CAR T-cell therapy through an interview with a young man who is undergoing this treatment at the National Institutes of Health in Bethesda for his refractory acute leukemia, along with interviewing his health care team. Through this series of dialogues, he eloquently gives his audience an understanding of CAR T-cell treatment and makes them understand its reference as a “living drug.” Stein simplifies a very complex concept, leaving the audience with a succinct understanding of the processing and power of this novel therapeutic strategy.